Skip to main content
. 2016 Jan 6;18(3):262–270. doi: 10.1016/j.hpb.2015.08.004

Table 1.

Baseline and intra-operative characteristics of patients with and without perioperative transfusion for perihilar cholangiocarcinoma. Variables are expressed as numbers (count) and percentages, unless stated otherwise

Variable Total (N = 145) No transfusion N = 65 Transfusion N = 80 P-valuea
Age (years), mean (sd) 63 ± 11.1 66 ± 10.7 59 ± 10.7 0.001
Sex 0.108
 Female 56 21 (37.5) 35 (62.5)
 Male 89 44 (49.4) 45 (50.6)
ASA classification 0.389
 1–2 126 54 (42.9) 72 (57.1)
 3 16 8 (50.0) 8 (50.0)
Jaundice at presentation 0.050
 No 30 18 (60.0) 12 (40.0)
 Yes 112 46 (41.1) 66 (58.9)
Preoperative biliary drainage 0.074
 No 19 11 (57.9) 8 (42.1)
 Percutaneous 5 1 (20.0) 4 (80.0)
 Endoscopic 89 44 (49.4) 45 (50.6)
 Both 32 9 (28.1) 23 (71.9)
Preoperative cholangitis 0.012
 No 105 55 (52.4) 50 (47.6)
 Yes 27 7 (25.9) 20 (74.1)
Preoperative total bilirubin (μmol/L), median (IQR) 14 ± 8 11 ± 10 19 ± 28 0.488
Preoperative hemoglobin, mean (sd) 7.9 ± 1.1 8.0 ± 1.0 7.8 ± 1.1 0.197
Blumgart classification 0.002
 1 70 40 (57.1) 30 (42.9)
 2 29 7 (24.1) 22 (75.9)
 3 22 6 (27.3) 16 (72.7)
Bismuth classification <0.001
 Left or right duct only 16 13 (81.2) 3 (18.8)
 1/2 41 29 (70.7) 12 (29.3)
 3A/B 69 17 (24.6) 52 (75.4)
 4 19 6 (31.6) 13 (68.4)
Type of resection 0.001
 No major hepatectomy 43 29 (67.4) 14 (32.6)
 (Ext.) left hepatectomy 54 23 (42.6) 31 (57.4)
 (Ext.) right hepatectomy 48 13 (27.1) 35 (72.9)
Caudate lobe resection 0.129
 No 65 33 (50.8) 32 (49.2)
 Yes 80 32 (40.0) 48 (60.0)
PV reconstruction 0.023
 No 118 58 (49.2) 60 (50.8)
 Yes 27 7 (25.9) 20 (74.1)
Blood loss (100 ml), mean (sd) 22.8 ± 15.4 12.5 ± 6.9 31.8 ± 15.1 <0.001
Major post-operative complications (Clavien grade 3 or 4) 0.002
 No 94 51 (54.3) 43 (45.7)
 Yes 50 14 (28.0) 36 (72.0)

N, number of patients.